Sarepta Therapeutics, Inc. (SRPT)
NASDAQ·Healthcare·Biotechnology
$19.65
-4.93%
Mkt Cap $2.21B
Analyst Ratings
Buy
1
Hold
1
Sell
3
Price Target (69 analysts)
$24.78
Range $14.00 – $35.00
Implied Upside
+26.1%
Consensus $24.78 vs current $19.65
NASDAQ·Healthcare·Biotechnology
$19.65
-4.93%
Mkt Cap $2.21B
Buy
1
Hold
1
Sell
3
Price Target (69 analysts)
$24.78
Range $14.00 – $35.00
+26.1%
Consensus $24.78 vs current $19.65